A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MBF / myocardial blood flow

[Related PubMed/MEDLINE]
Total Number of Papers: 1113
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MBF  (>> Co-occurring Abbreviation)
Long Form:   myocardial blood flow
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 "Apical thinning": Relations between myocardial wall thickness and apical left ventricular tracer uptake as assessed with positron emission tomography myocardial perfusion imaging. CT, MPI, PET
2020 15O-Water PET MPI: Current Status and Future Perspectives. CAD, FFR, MFR, PET
2020 15O-water positron emission tomography of myocardial ischemia in patients referred for percutaneous coronary intervention. CI, FFR, IMR, MFR, NPV, PCI, PET, PPV
2020 3D PET/CT 82Rb PET myocardial blood flow quantification: comparison of half-dose and full-dose protocols. 82Rb, CV, FD, HfD
2020 A Genetic Polymorphism in the Pannexin1 Gene Predisposes for The Development of Endothelial Dysfunction with Increasing BMI. BMI, CPT, MFR, Panx1, SNP
2020 A new cardiac phantom for dynamic SPECT. LV, SPECT, TACs
2020 Accelerated Wideband Myocardial Perfusion Pulse Sequence with Compressed Sensing Reconstruction for Myocardial Blood Flow Quantification in Patients with a Cardiac Implantable Electronic Device. CIED, LVEF, MP, SVS
2020 Activity regimes for 82Rb cardiac PET: Effects on absolute MBF and MPI. EF, MFR, MPI, TPD
2020 Added value of myocardial blood flow using 18F-flurpiridaz PET to diagnose coronary artery disease: The flurpiridaz 301 trial. MFR
10  2020 Added Value of Transluminal Attenuation Gradient to Qualitative CCTA Ischemia Detection as Determined by 13N-ammonia PET Quantitative Myocardial Perfusion. AUC, CAD, CCTA, MFR, PET, TAG
11  2020 An Experimental Series Investigating the Effects of Hyperinsulinemic Euglycemia on Myocardial Blood Flow Reserve in Healthy Individuals and on Myocardial Perfusion Defect Size following ST-Segment Elevation Myocardial Infarction. HE, MBFR, STEMI
12  2020 Clinical usefulness of quantification of myocardial blood flow and flow reserve using CZT-SPECT for detecting coronary artery disease in patients with normal stress perfusion imaging. CAD, CAG, CKD, CZT, DM, MPR, MPS, SPECT
13  2020 Comparative Prognostic and Diagnostic Value of Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation. CAV, MFR
14  2020 Comparison between ticagrelor and clopidogrel on myocardial blood flow in patients with acute coronary syndrome, using 13 N-ammonia positron emission tomography. ACS, PCI, PET
15  2020 Coronary artery calcium burden, carotid atherosclerotic plaque burden, and myocardial blood flow in patients with end-stage renal disease: A non-invasive imaging study combining PET/CT and 3D ultrasound. CACS, CFR, cPB, CV, ESRD
16  2020 Coronary artery stenosis-related perfusion ratio using dynamic computed tomography myocardial perfusion imaging: a pilot for identification of hemodynamically significant coronary artery disease. CAD, CTA, CTP, FFR, ICA, QPR
17  2020 Coronary Microvascular Dysfunction: Clinical Considerations and Noninvasive Diagnosis. MVD
18  2020 Deep-Learning-Based Preprocessing for Quantitative Myocardial Perfusion MRI. DL, ICC
19  2020 Diagnostic accuracy of stress myocardial computed tomography perfusion imaging to detect myocardial ischemia: a comparison with coronary flow velocity reserve derived from transthoracic Doppler echocardiography. ATP, CFVR, CTP, LAD, TTDE
20  2020 Diagnostic analysis of new quantitative parameters of low-dose dynamic myocardial perfusion imaging with CZT SPECT in the detection of suspected or known coronary artery disease. CAD, MFR, RFR, RMBF, sMBF
21  2020 Diagnostic performance of quantitative, semi-quantitative, and visual analysis of dynamic CT myocardial perfusion imaging: a validation study with invasive fractional flow reserve. AUC, CT-MPI, FFR
22  2020 Diagnostic Value of Lesion-specific Measurement of Myocardial Blood Flow Using Hybrid PET/CT. CAG, CT, LAD, PET
23  2020 Direct List Mode Parametric Reconstruction for Dynamic Cardiac SPECT. TAC
24  2020 Discordance between invasive coronary flow reserve (CFR) and non-invasive myocardial flow reserve (MFR) in diffuse coronary ectasia (DCE). CFR, DCE, MFR, MPI, PET
25  2020 Dynamic CT Myocardial Perfusion Imaging in Patients without Obstructive Coronary Artery Disease: Quantification of Myocardial Blood Flow according to Varied Heart Rate Increments after Stress. bpm, CCTA, CT-MPI, HR
26  2020 Early onset of left ventricular regional asynchrony in arteries with sub-clinical stenosis. BW, MFR, SRS, SSS
27  2020 Emerging F-18-Labelled PET Myocardial Perfusion Tracers. MPI
28  2020 Enhanced external counterpulsation improves cardiac function in Beagles after cardiopulmonary resuscitation. EECP, ROSC
29  2020 Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics. FGF23, GLP-1, LV, MPR
30  2020 Impact of Abnormal Remote Stress Myocardial Blood Flow by Dynamic CT Perfusion on Clinical Outcomes. CI, CTP, HR
31  2020 Impact of attenuation correction for CZT-SPECT measurement of myocardial blood flow. CZT, MFR
32  2020 Impact of the Choice of Native T1 in Pixelwise Myocardial Blood Flow Quantification. DCE
33  2020 Improved regional myocardial blood flow and flow reserve after coronary revascularization as assessed by serial 15O-water positron emission tomography/computed tomography. CABG, CAD, MFR, PCI
34  2020 Incremental prognostic value of hybrid [15O]H2O positron emission tomography-computed tomography: combining myocardial blood flow, coronary stenosis severity, and high-risk plaque morphology. CAD, CCTA, HR, HRP, MI, PET
35  2020 Ischaemic burden and changes in absolute myocardial perfusion after chronic total occlusion percutaneous coronary intervention. CFR, CTO, PCI
36  2020 Low-dose dobutamine stress myocardial contrast echocardiography for the evaluation of myocardial microcirculation and prediction of overall cardiac function recovery. AMI, CSI, MCE
37  2020 Measuring SPECT myocardial blood flow at the University of Ottawa Heart Institute. ---
38  2020 Microvascular Angina Diagnosed by Absolute PET Myocardial Blood Flow Quantification. PET
39  2020 Myocardial blood flow analysis of stress dynamic myocardial CT perfusion for hemodynamically significant coronary artery disease diagnosis: The clinical value of relative parameter optimization. CAD, CTP, ICA/FFR
40  2020 Myocardial blood flow and cardiac sympathetic innervation in young adults late after arterial switch operation for transposition of the great arteries. ASO, mHED, PET, TGA
41  2020 Myocardial Coverage and Radiation Dose in Dynamic Myocardial Perfusion Imaging Using Third-Generation Dual-Source CT. LV
42  2020 Myocardial Perfusion Imaging Using Positron Emission Tomography. CAD, CFR, MPI, PET
43  2020 Noninvasive estimation of quantitative myocardial blood flow with Tc-99m MIBI by a compartment model analysis in rat. MPI, ROI, TP
44  2020 PET and SPECT Tracers for Myocardial Perfusion Imaging. MFR, MPI
45  2020 Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. HCM, NSVT, PET
46  2020 Preclinical Validation of a Single-Scan Rest/Stress Imaging Technique for 13N-Ammonia Positron Emission Tomography Cardiac Perfusion Studies. ---
47  2020 Prognostic implication of global myocardial blood flow in patients with ST-segment elevation myocardial infarction. CMR, LGE, LVEF, MACE, MVO, POCO, STEMI
48  2020 Prognostic utility of longitudinal quantification of PET myocardial blood flow early post heart transplantation. CAV, CVR, HT, MFR, PET
49  2020 Quantification of myocardial blood flow (MBF) and reserve (MFR) incorporated with a novel segmentation approach: Assessments of quantitative precision and the lower limit of normal MBF and MFR in patients. CAD, LLN, MFR, PET
50  2020 Quantification of Myocardial Blood Flow by Machine Learning Analysis of Modified Dual Bolus MRI Examination. MRI, PET, RF, SVM
51  2020 Quantification of myocardial blood flow with 11C-hydroxyephedrine dynamic PET: comparison with 15O-H2O PET. HED, SNS
52  2020 Quantification of myocardial perfusion reserve by CZT-SPECT: A head to head comparison with 82Rubidium PET imaging. CAD
53  2020 Quantitative assessment of myocardial blood flow and extracellular volume fraction using 68Ga-DOTA-PET: A feasibility and validation study in large animals. 68Ga, ECV
54  2020 Quantitative myocardial perfusion 82Rb-PET assessed by hybrid PET/coronary-CT: Normal values and diagnostic performance. CCTA, MFR, sMBF
55  2020 Rationale and design of the quantification of myocardial blood flow using dynamic PET/CTA-fused imagery (DEMYSTIFY) to determine physiological significance of specific coronary lesions. CTA, DEMYSTIFY, DEMYSTIFY, dPET, FFR, ICA
56  2020 Reduced acquisition times for measurement of myocardial blood flow with 99mTc-tetrofosmin and solid-state detector SPECT. ---
57  2020 Reduced myocardial blood flow reserve in kidney transplant candidates may hamper risk stratification. CAC, ESKD
58  2020 Reduced Myocardial Perfusion Reserve in Type 2 Diabetes Is Caused by Increased Perfusion at Rest and Decreased Maximal Perfusion During Stress. ---
59  2020 Reducing motion-correction-induced variability in 82rubidium myocardial blood-flow quantification. ---
60  2020 Regadenoson dynamic computed tomography myocardial perfusion using low-dose protocol for evaluation of the ischemic burden. ULYSSES study. CTP, MBV, MR MPI, PCBV, PV, TTP
61  2020 Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera. MFR, MPI
62  2020 Selection of PET Camera and Implications on the Reliability and Accuracy of Absolute Myocardial Blood Flow Quantification. iNEC
63  2020 Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy. AFib, HF, IMWT, LV-GLS
64  2020 Simplified quantification of 13N-ammonia PET myocardial blood flow: A comparative study with the standard compartment model to facilitate clinical use. HVT, MFR
65  2020 Software reproducibility of myocardial blood flow and flow reserve quantification in ischemic heart disease: A 13N-ammonia PET study. MFR, SPs
66  2020 Stimulation of the hepatic arterial buffer response using exogenous adenosine: hepatic rest/stress perfusion imaging. HAP, HAPI, MPI, RP, SP
67  2020 Stress dynamic myocardial CT perfusion for symptomatic patients with intermediate- or high-risk of coronary artery disease: Optimization and incremental improvement between the absolute and relative myocardial blood flow analysis. AUCs, CAD, CTP
68  2020 Stress Myocardial Blood Flow Ratio by Dynamic CT Perfusion Identifies Hemodynamically Significant CAD. CTA, CTP, SFR
69  2020 Test-Retest Precision of Myocardial Blood Flow Measurements With 99mTc-Tetrofosmin and Solid-State Detector Single Photon Emission Computed Tomography. COV, SPECT
70  2020 The Prognostic Significance of Quantitative Myocardial Perfusion: An Artificial Intelligence-Based Approach Using Perfusion Mapping. MACE
71  2020 The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes. MACE
72  2020 Therapeutic Ultrasound Improves Myocardial Blood Flow and Reduces Infarct Size in a Canine Model of Coronary Microthromboembolism. IS, TUS
73  2020 Validation of multiparametric rubidium-82 PET myocardial blood flow quantification for cardiac allograft vasculopathy surveillance. cMFR, CVR, IVUS, PET
74  2020 Validation of regional myocardial blood flow quantification using three-dimensional PET with rubidium-82: repeatability and comparison with two-dimensional PET data acquisition. MFR, Rb
75  2020 Value of CMR and PET in Predicting Ventricular Arrhythmias in Ischemic Cardiomyopathy Patients Eligible for ICD. CFR, CMR, HR, ICD, LGE, LV, LVEDVI, LVEF, PET, VAs
76  2020 Value of SiPM PET in myocardial perfusion imaging using Rubidium-82. MFR, MPI, PMT PET, Rb-82, SiPM PET
77  2019 A combined static-dynamic single-dose imagingprotocol to compare quantitative dynamic SPECT with static conventional SPECT. CAD, CFR, MPI, SCA
78  2019 A robust segmentation method with triple-factor non-negative matrix factorization for myocardial blood flow quantification from dynamic 82 Rb positron emission tomography. LV, MFR, PET, ROIs, TACs, TNMF
79  2019 Absolute myocardial blood flows derived by dynamic CZT scan vs invasive fractional flow reserve: Correlation and accuracy. CFR, FD, FFR, ICA
80  2019 Accelerated, first-pass cardiac perfusion pulse sequence with radial k-space sampling, compressed sensing, and k-space weighted image contrast reconstruction tailored for visual analysis and quantification of myocardial blood flow. CS, KWIC
81  2019 Accuracy of Myocardial Blood Flow Estimation From Dynamic Contrast-Enhanced Cardiac CT Compared With PET. CT, PET
82  2019 Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study. CMR, MBFcor, MVO, STEMI
83  2019 Assessing Reliability of Myocardial Blood Flow After Motion Correction With Dynamic PET Using a Bayesian Framework. SNR
84  2019 Assessment of Coronary Flow Velocity Reserve in the Left Main Trunk Using Phase-contrast MR Imaging at 3T: Comparison with 15O-labeled Water Positron Emission Tomography. CAD, CFVR, LMT, MFR, MRI, PET
85  2019 Assessment of motion correction in dynamic rubidium-82 cardiac PET with and without frame-by-frame adjustment of attenuation maps for calculation of myocardial blood flow. MC, NC
86  2019 Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy. MFR, PH
87  2019 Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMRtoDetect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology. CMR, FFR, IMR, MPR, MVD
88  2019 Automatic myocardial ischemic lesion detection on magnetic resonance perfusion weighted imaging prior perfusion quantification: A pre-modeling strategy. CMR, STRG
89  2019 Blood pool and tissue phase patient motion effects on 82rubidium PET myocardial blood flow quantification. 82Rb
90  2019 Calibration-free beam hardening correction for myocardial perfusion imaging using CT. ABHC, BH, CT-MPI, HAM, ROI
91  2019 Characterization of functionally significant coronary artery disease by a coronary computed tomography angiography-based index: a comparison with positron emission tomography. CAD, CCTA, CI, MFR, PET, vFAI
92  2019 Chronic total occlusion or non-chronic total occlusion percutaneous coronary intervention: Do myocytes really care? CFR
93  2019 Comparison between N13NH3-PET and 99mTc-Tetrofosmin-CZT SPECT in the evaluation of absolute myocardial blood flow and flow reserve. AC, CZT, MFR, MFR
94  2019 Comparison between quantitative cardiac magnetic resonance perfusion imaging and [15O]H2O positron emission tomography. CAD, CMR, MFR, PET
95  2019 Comparison of maximal Rubidium-82 activitiesformyocardial blood flow quantification between digital and conventional PET systems. ---
96  2019 Comparison of two software systems for quantification of myocardial blood flow in patients withhypertrophic cardiomyopathy. CAD, CAD, HCM, LVOT, MFR, PET
97  2019 Coronary vascular function in patients with resistant hypertension and normal myocardial perfusion: a propensity score analysis. CAC, CAD, MPR, RH
98  2019 Corrected coronary opacification decrease from coronary computed tomography angiography: Validation with quantitative 13N-ammonia positron emission tomography. CCO, CCTA, MPI, PET, RFR
99  2019 Detection of Hemodynamically Significant Coronary Stenosis: CT Myocardial Perfusion versus Machine Learning CT Fractional Flow Reserve. AUC, CCA, FFR, ML, MPI, ROC
100  2019 Diagnostic value of longitudinal flow gradient for the presence of haemodynamically significant coronary artery disease. CAD, FFR, PET